EOS begins clinical trial

AuntMinnie.com staff writers
Jan 31, 2007

Medical device firm Electro-Optical Sciences (EOS) has begun a clinical trial for its MelaFind skin imaging device.

Designed to improve the early diagnosis of melanoma, MelaFind emits light of multiple wavelengths to capture images of suspicious pigmented skin lesions and extract data, according to the Irvington, NY-based firm. The data are then analyzed against a proprietary database of melanomas and benign lesions to provide information and produce a recommendation of whether the lesion should be biopsied, EOS said.

EOS anticipates it will submit a premarket approval (PMA) application for MelaFind in the second half of 2007.

By AuntMinnie.com staff writers
February 1, 2007

Copyright © 2007 AuntMinnie.com

Latest in Body Imaging
MRI images of a knee joint of a patient showing (left) severe cartilage defects compared to a patient with an intact knee joint. Image courtesy of Upadhyay Bharadwaj, MD
MRI muscle volumes linked to risk of TKRs
November 27, 2023
2023 08 15 20 59 1662 2023 08 15 Ai Lymphoma 20230815200315
AI outperforms clinical scores in high-risk lymphoma patients
August 15, 2023
2023 07 18 20 20 0856 2023 07 18 Gadopiclinol 400 20230718200726
Gadopiclenol comparable to gadobutrol at half-dose for body MRI
July 18, 2023
2023 06 28 18 01 2744 Wong Ka Kit 400
Video from SNMMI: PET tracer shows promise for adrenal gland tumors
June 28, 2023
More in Body Imaging
MRI muscle volumes linked to risk of TKRs
By Will Morton
Having stronger thigh muscles may lower the odds of total knee replacement (TKR) surgery in patients with osteoarthritis.
November 27, 2023
MRI images of a knee joint of a patient showing (left) severe cartilage defects compared to a patient with an intact knee joint. Image courtesy of Upadhyay Bharadwaj, MD
AI outperforms clinical scores in high-risk lymphoma patients
By Will Morton
Researchers have developed an AI algorithm for reading FDG-PET/CT scans that outperforms standard clinical scores used to identify high-risk lymphoma patients, according to a study published August 12 in Scientific Reports.
August 15, 2023
2023 08 15 20 59 1662 2023 08 15 Ai Lymphoma 20230815200315
Gadopiclenol comparable to gadobutrol at half-dose for body MRI
By Kate Madden Yee
Gadopiclenol at half the dose of gadobutrol is just as effective for lesion evaluation on contrast-enhanced body MRI exams, according to research published on July 18 in Radiology.
July 18, 2023
2023 07 18 20 20 0856 2023 07 18 Gadopiclinol 400 20230718200726
Video from SNMMI: PET tracer shows promise for adrenal gland tumors
CHICAGO - In this interview with AuntMinnie.com at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, nuclear medicine physician Ka Kit Wong, MD, discusses a new PET radiotracer that shows promise in detecting adrenal gland tumors.
June 28, 2023
2023 06 28 18 01 2744 Wong Ka Kit 400
SNMMI Image of the Year shows potential for pancreatic cancer theranostics
By Will Morton
CHICAGO - A new theranostic pair for imaging and treatment of pancreatic cancer has won the Image of the Year award at the 2023 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 26, 2023
2023 06 24 23 36 0349 2023 06 24 Dota5g 20230624230737
Medical IP secures FDA clearance for CT body composition analysis AI
By AuntMinnie.com staff writers
South Korean AI firm Medical IP has secured clearance from the U.S. Food and Drug Administration (FDA) for its CT-based automatic body composition analysis AI software, DeepCatch.
June 25, 2023
2020 12 11 00 53 7811 Fat Tissue Adipocytes 400
SNMMI: New theranostics pair shows promise in pancreatic cancer
By Will Morton
CHICAGO - A new theranostics imaging and treatment approach shows promise in patients with pancreatic cancer, according to research presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 23, 2023
2023 06 24 23 36 0349 2023 06 24 Dota5g 20230624230737
GE touts first patient scanned in PET imaging trial
By AuntMinnie.com staff writers
GE HealthCare had its first patient scanned in a phase I clinical trial for an investigational F-18 CD8-targeted PET imaging radiopharmaceutical.
June 15, 2023
2021 11 30 16 39 4000 Ge Rsna 2021 400
ISMRM: Online MRI safety screening reduces workflow delays
By Kate Madden Yee
TORONTO - Online screening for patient safety concerns prior to MR imaging effectively reduces workflow delays, according to poster research results presented June 6 at the International Society for Magnetic Resonance in Medicine (ISMRM) meeting.
June 6, 2023
2023 06 01 17 57 3254 Toronto 400
Dr. Baeßler radiomics keynote
Bettina Baeßler, MD, from University Hospital Würzburg in Germany gave at keynote on the state of MR radiomics at the ISMRM annual meeting in Toronto. She discussed the need for standardization and better-quality studies in this area.
June 3, 2023
ISMRM: Whole-body MRI sheds light on how fat is stored in men and women
By Will Morton
TORONTO - Whole-body MRI scans reveal significant differences in how fat is stored in men and women, according to research presented at the International Society for Magnetic Resonance in Medicine (ISMRM) meeting.
June 2, 2023
2020 12 11 00 53 7811 Fat Tissue Adipocytes 400
Belgian researcher discusses CT's benefits for assessing myosteatosis
AuntMinnie.com spoke with Dr. Maxime Nachit, PhD, of the University of Louvain in Brussels about how CT imaging helps assess asymptomatic patients' muscle fat accumulation -- a condition that can increase risk of adverse cardiovascular events.
May 17, 2023
2023 05 17 18 42 6868 2023 05 17 Maxime Nachit Resized
Page 1 of 20
Next Page